The short version
15 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Norethindrone Acetate
Norethindrone · NORETHINDRONE ACETATE 5 mg/1 · Tablet · Oral · AvKARE
NDC 42291-0650-90 · 90 TABLET in 1 BOTTLE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$165.18
Reported to Texas DSHS · 2026 annual filing · AvKare
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for norethindrone (oral solid) in the next 90 days
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Regulatory
- Application
- ANDA200275
- TE code
- AB
- Approval date
- Jul 30, 2012
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Norethindrone (Tablet)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Aurobindo Pharma Limited | NORETHINDRONE .35 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| A-S Medication Solutions | NORETHINDRONE .35 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Afaxys Pharma, LLC | NORETHINDRONE .35 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Amneal Pharmaceuticals LLC | NORETHINDRONE ACETATE 5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| AvKARE | NORETHINDRONE ACETATE 5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Mylan Pharmaceuticals Inc. | NORETHINDRONE .35 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Naari Pte. Limited | NORETHINDRONE .35 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Teva Pharmaceuticals, Inc. | NORETHINDRONE .35 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Xiromed LLC | NORETHINDRONE .35 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Xiromed, LLC | NORETHINDRONE .35 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Glenmark Pharmaceuticals Inc., USA | NORETHINDRONE .35 mg/1 | Jul 15, 2026 | Aug 31, 2026 |
| Proficient Rx LP | NORETHINDRONE .35 mg/1 | Jul 15, 2026 | Aug 31, 2026 |
| Dr. Reddy's Labratories Inc. | NORETHINDRONE .35 mg/1 | Jul 15, 2026 | Aug 28, 2026 |
| Lupin Pharmaceuticals, Inc. | NORETHINDRONE .35 mg/1 | Jul 15, 2026 | Aug 28, 2026 |
| Mayne Pharma Inc. | NORETHINDRONE .35 mg/1 | Jul 15, 2026 | Aug 28, 2026 |
| Apotex Corp. | NORETHINDRONE .35 mg/1 | Jul 15, 2026 | Jul 29, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Norethindrone Acetate — NDC 42291-0650-90," retrieved September 3, 2026, https://drugdashboards.com/drug/42291065090.
Free to cite with attribution — see how the data is put together.